86 related articles for article (PubMed ID: 25172040)
1. Human epididymis protein 4: factors of variation.
Ferraro S; Schiumarini D; Panteghini M
Clin Chim Acta; 2015 Jan; 438():171-7. PubMed ID: 25172040
[TBL] [Abstract][Full Text] [Related]
2. The importance of individual biology in the clinical use of serum biomarkers for ovarian cancer.
Braga F; Ferraro S; Mozzi R; Panteghini M
Clin Chem Lab Med; 2014 Nov; 52(11):1625-31. PubMed ID: 24829196
[TBL] [Abstract][Full Text] [Related]
3. Human epididymis protein 4 (HE4) in laboratory medicine and an algorithm in renal disorders.
Kappelmayer J; Antal-Szalmás P; Nagy B
Clin Chim Acta; 2015 Jan; 438():35-42. PubMed ID: 25127713
[TBL] [Abstract][Full Text] [Related]
4. Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review.
Ferraro S; Braga F; Lanzoni M; Boracchi P; Biganzoli EM; Panteghini M
J Clin Pathol; 2013 Apr; 66(4):273-81. PubMed ID: 23426716
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic value of combining detection of human epididymis protein 4 and CA125 in patients with malignant ovarian carcinoma].
Wang MJ; Qi J; Wang H; Li XX; Wei BJ; Fu C; Gao J; Han BB
Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):540-3. PubMed ID: 22093635
[TBL] [Abstract][Full Text] [Related]
6. Is serum human epididymis protein 4 ready for prime time?
Ferraro S; Panteghini M
Ann Clin Biochem; 2014 Mar; 51(Pt 2):128-36. PubMed ID: 24031041
[TBL] [Abstract][Full Text] [Related]
7. [Ovarian tumor markers of presumed benign ovarian tumors].
Lahlou N; Brun JL
J Gynecol Obstet Biol Reprod (Paris); 2013 Dec; 42(8):752-9. PubMed ID: 24210243
[TBL] [Abstract][Full Text] [Related]
8. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
9. Two-marker combinations for preoperative discrimination of benign and malignant ovarian masses.
Freydanck MK; Laubender RP; Rack B; Schuhmacher L; Jeschke U; Scholz C
Anticancer Res; 2012 May; 32(5):2003-8. PubMed ID: 22593479
[TBL] [Abstract][Full Text] [Related]
10. Stability of HE4 and CA125 in blood samples from patients diagnosed with ovarian cancer.
Sandhu N; Karlsen MA; Høgdall C; Laursen IA; Christensen IJ; Høgdall EV
Scand J Clin Lab Invest; 2014 Sep; 74(6):477-84. PubMed ID: 24724578
[TBL] [Abstract][Full Text] [Related]
11. Serum concentrations of HE4 change little during in vitro fertilization.
Hallamaa M; Huhtinen K; Suvitie P; Perheentupa A
Acta Obstet Gynecol Scand; 2014 Jul; 93(7):640-6. PubMed ID: 24734893
[TBL] [Abstract][Full Text] [Related]
12. Effect of human epididymis protein 4 gene silencing on the malignant phenotype in ovarian cancer.
Zou SL; Chang XH; Ye X; Cheng HY; Cheng YX; Tang ZJ; Zhang ZJ; Gao L; Chen XH; Cui H
Chin Med J (Engl); 2011 Oct; 124(19):3133-40. PubMed ID: 22040568
[TBL] [Abstract][Full Text] [Related]
13. HE4 in ovarian cancer: from discovery to clinical application.
Montagnana M; Danese E; Giudici S; Franchi M; Guidi GC; Plebani M; Lippi G
Adv Clin Chem; 2011; 55():1-20. PubMed ID: 22126021
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of HE4 as an extrabiomarker to CA125 to improve detection of ovarian carcinoma: is it time for a step forward?
Azzam AZ; Hashad DI; Kamel NA
Arch Gynecol Obstet; 2013 Jul; 288(1):167-72. PubMed ID: 23361457
[TBL] [Abstract][Full Text] [Related]
15. Human epididymis protein 4 (HE4) and ovarian cancer prognosis.
Trudel D; Têtu B; Grégoire J; Plante M; Renaud MC; Bachvarov D; Douville P; Bairati I
Gynecol Oncol; 2012 Dec; 127(3):511-5. PubMed ID: 22967799
[TBL] [Abstract][Full Text] [Related]
16. The reference intervals for HE4, CA125 and ROMA in healthy female with electrochemiluminescence immunoassay.
Yang J; Sa M; Huang M; Yang J; Xiang Z; Liu B; Tang A
Clin Biochem; 2013 Nov; 46(16-17):1705-8. PubMed ID: 24012857
[TBL] [Abstract][Full Text] [Related]
17. [HE4--a new tumor marker for ovarian cancer].
Manolov V; Marinov B; Vasilev V; Andreeva A
Akush Ginekol (Sofiia); 2011; 50 Suppl 2():11-5. PubMed ID: 22524132
[TBL] [Abstract][Full Text] [Related]
18. Making new biomarkers a reality: the case of serum human epididymis protein 4.
Ferraro S; Panteghini M
Clin Chem Lab Med; 2019 Aug; 57(9):1284-1294. PubMed ID: 30511925
[TBL] [Abstract][Full Text] [Related]
19. Physiopathological factors affecting the diagnostic value of serum HE4-test for gynecologic malignancies.
Qu W; Li J; Duan P; Tang Z; Guo F; Chen H; Zhu X; Jiang SW
Expert Rev Mol Diagn; 2016 Dec; 16(12):1271-1282. PubMed ID: 27784171
[TBL] [Abstract][Full Text] [Related]
20. HE4 tissue expression in borderline ovarian tumors: a pilot study by the tumorbank ovarian cancer network.
Nassir M; Darb-Esfahani S; Richter R; Chekerov R; Hall C; Muallem MZ; Denkert C; Stamatian F; Fotopoulou C; Sehouli J; Braicu EI
Anticancer Res; 2013 Apr; 33(4):1673-7. PubMed ID: 23564814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
